151 related articles for article (PubMed ID: 29990619)
1. Apolipoprotein(a) inhibits the conversion of Glu-plasminogen to Lys-plasminogen on the surface of vascular endothelial and smooth muscle cells.
Romagnuolo R; DeMarco K; Scipione CA; Boffa MB; Koschinsky ML
Thromb Res; 2018 Sep; 169():1-7. PubMed ID: 29990619
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein(a) inhibits the conversion of Glu-plasminogen to Lys-plasminogen: a novel mechanism for lipoprotein(a)-mediated inhibition of plasminogen activation.
Feric NT; Boffa MB; Johnston SM; Koschinsky ML
J Thromb Haemost; 2008 Dec; 6(12):2113-20. PubMed ID: 18983515
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein(a) inhibits in vitro tube formation in endothelial cells: identification of roles for Kringle V and the plasminogen activation system.
Liu L; Boffa MB; Koschinsky ML
PLoS One; 2013; 8(1):e52287. PubMed ID: 23326327
[TBL] [Abstract][Full Text] [Related]
4. The solution phase interaction between apolipoprotein(a) and plasminogen inhibits the binding of plasminogen to a plasmin-modified fibrinogen surface.
Sangrar W; Gabel BR; Boffa MB; Walker JB; Hancock MA; Marcovina SM; Horrevoets AJ; Nesheim ME; Koschinsky ML
Biochemistry; 1997 Aug; 36(34):10353-63. PubMed ID: 9265615
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of vascular smooth muscle cell proliferation and migration by apolipoprotein(a) is dependent on inhibition of transforming growth factor-beta activation and on the presence of kringle IV type 9.
O'Neil CH; Boffa MB; Hancock MA; Pickering JG; Koschinsky ML
J Biol Chem; 2004 Dec; 279(53):55187-95. PubMed ID: 15498766
[TBL] [Abstract][Full Text] [Related]
6. Definition of the structural elements in plasminogen required for high-affinity binding to apolipoprotein(a): a study utilizing surface plasmon resonance.
Hancock MA; Spencer CA; Koschinsky ML
Biochemistry; 2004 Sep; 43(38):12237-48. PubMed ID: 15379562
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of pericellular plasminogen activation by apolipoprotein(a): Roles of urokinase plasminogen activator receptor and integrins α
Romagnuolo R; Scipione CA; Bazzi ZA; Boffa MB; Koschinsky ML
Atherosclerosis; 2018 Aug; 275():11-21. PubMed ID: 29852400
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of plasminogen activation by apo(a): role of carboxyl-terminal lysines and identification of inhibitory domains in apo(a).
Romagnuolo R; Marcovina SM; Boffa MB; Koschinsky ML
J Lipid Res; 2014 Apr; 55(4):625-34. PubMed ID: 24478033
[TBL] [Abstract][Full Text] [Related]
9. Dual effect of apolipoprotein(a) on plasmin(ogen)-induced apoptosis through modulation of cell detachment of adherent cells.
Ho-Tin-Noé B; Meilhac O; Rossignol P; Lijnen HR; Anglés-Cano E
Thromb Haemost; 2006 Jan; 95(1):142-50. PubMed ID: 16543973
[TBL] [Abstract][Full Text] [Related]
10. Conversion of Glu-plasminogen to Lys-plasminogen is necessary for optimal stimulation of plasminogen activation on the endothelial cell surface.
Gong Y; Kim SO; Felez J; Grella DK; Castellino FJ; Miles LA
J Biol Chem; 2001 Jun; 276(22):19078-83. PubMed ID: 11264290
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein(a) and plasminogen interactions with fibrin: a study with recombinant apolipoprotein(a) and isolated plasminogen fragments.
Rouy D; Koschinsky ML; Fleury V; Chapman J; Anglés-Cano E
Biochemistry; 1992 Jul; 31(27):6333-9. PubMed ID: 1627572
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein(a): structure-function relationship at the lysine-binding site and plasminogen activator cleavage site.
Anglés-Cano E; Rojas G
Biol Chem; 2002 Jan; 383(1):93-9. PubMed ID: 11928826
[TBL] [Abstract][Full Text] [Related]
13. Neutrophils stimulated by apolipoprotein(a) generate fragments that are stronger inhibitors of plasmin formation than apo(a).
Lamanuzzi LB; Mtairag el M; Pepe G; Anglés-Cano E
Thromb Haemost; 2004 Nov; 92(5):1066-75. PubMed ID: 15543335
[TBL] [Abstract][Full Text] [Related]
14. Antifibrinolytic effect of recombinant apolipoprotein(a) in vitro is primarily due to attenuation of tPA-mediated Glu-plasminogen activation.
Sangrar W; Bajzar L; Nesheim ME; Koschinsky ML
Biochemistry; 1995 Apr; 34(15):5151-7. PubMed ID: 7711034
[TBL] [Abstract][Full Text] [Related]
15. Endothelial cell-mediated conversion of Glu-plasminogen to Lys-plasminogen. Further evidence for assembly of the fibrinolytic system on the endothelial cell surface.
Hajjar KA; Nachman RL
J Clin Invest; 1988 Nov; 82(5):1769-78. PubMed ID: 3141482
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of Apo(a) kringle IV-10 and plasminogen kringles on the interactions of lipoprotein(a) with regulatory molecules.
Xue S; Green MA; LoGrasso PV; Boettcher BR; Madison EL; Curtiss LK; Miles LA
Thromb Haemost; 1999 Mar; 81(3):428-35. PubMed ID: 10102473
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of plasminogen activation by lipoprotein(a): critical domains in apolipoprotein(a) and mechanism of inhibition on fibrin and degraded fibrin surfaces.
Hancock MA; Boffa MB; Marcovina SM; Nesheim ME; Koschinsky ML
J Biol Chem; 2003 Jun; 278(26):23260-9. PubMed ID: 12697748
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the interaction of recombinant apolipoprotein(a) with modified fibrinogen surfaces and fibrin clots.
Sangrar W; Koschinsky ML
Biochem Cell Biol; 2000; 78(4):519-25. PubMed ID: 11012092
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of fibrinolysis by lipoprotein(a).
Anglés-Cano E; de la Peña Díaz A; Loyau S
Ann N Y Acad Sci; 2001; 936():261-75. PubMed ID: 11460483
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the mechanism of lipoprotein(a) assembly.
Koschinsky ML; Marcovina SM; May LF; Gabel BR
Clin Genet; 1997 Nov; 52(5):338-46. PubMed ID: 9520124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
